
CNBC Daily Open: Elon Musk's companies aren't fully self-driving and await his steering
In his first week away from the U.S. government's so-called Department of Government Efficiency, Elon Musk is seeing positive activity in his companies. His brain tech startup Neuralink announced a $650 million funding round, while his electric vehicle manufacturer Tesla in May enjoyed a 213% year-on-year jump in sales in Norway.
Granted, Tesla's encouraging numbers in Norway are an outlier amid a plunge in Europe sales. And the causal link between those rosy developments and Musk's departure from DOGE is tenuous. Starlink's funding round and Tesla's increase in Norway sales occurred while Musk still had his hands full with the White House. Hence, they could have happened with little — or none — of his leadership or input.
But both outcomes serve as reminders of why so many are Musk backers: His companies are, fundamentally, successful ones. Tesla still has a market capitalization of over $1 trillion, and Musk is seeking a valuation of more than $120 billion for his artificial intelligence startup xAI — by contrast, rivals Perplexity AI and Anthropic are looking for valuations at $14 billion and $61.5 billion, respectively.
While Musk's firms still deserve investor attention, they, like Tesla's promised full self-driving feature, aren't completely autonomous. They need a steady — and ideally "super focused" — hand to guide them for the road ahead.
Muted start to JuneU.S. stocks posted modest gains Monday, the first trading day of June. The S&P 500 advanced 0.41%, the Dow Jones Industrial Average edged up 0.08% and the Nasdaq Composite rose 0.67%. Asia-Pacific markets climbed Tuesday. Hong Kong's Hang Seng Index gained 1.17%, while Japan's Nikkei 225 inched up 0.07% at 2 p.m. Singapore time.
China's factory activity in May falls sharplyThe Caixin/S&P Global manufacturing purchasing managers' index fell to 48.3 in May from 50.4 in April, meaning China's factory activity shrank last month. The reading sharply missed Reuters' estimates of 50.6 and was the steepest drop since 2022. A gauge for new export orders fell to its lowest level since July 2023, Caixin said, indicating foreign demand is slowing because of U.S. tariffs.
Steel tariffs will hike U.S. pricesThe 50% tariff on steel imports that U.S. President Donald Trump announced Friday will push up prices of the metal in America, according to analysts. "Already steel prices in the U.S. are higher than anywhere else, and it is a net importer which needs to have volumes coming in. All this does is raise prices there," Josh Spoores, head of steel Americas analysis at CRU, told CNBC on Monday.
Neuralink raised $650 millionElon Musk's Neuralink has closed a $650 million funding round, the brain tech startup announced Monday. ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and other firms participated in the round, according to a press release. Neuralink is building a brain-computer interface, a system that translates brain signals into commands for external technologies.
Tesla sales in Norway jumpTesla's sale of new cars in Norway skyrocketed 213% to 2,600 in May from a year earlier, according to official data. The increase was mostly driven by sales of the firm's revamped Model Y compact sport utility vehicle. That bucks a downward trend across Europe — industry groups on Monday reported significantly lower May sales for new Tesla vehicles in Spain, Portugal, Denmark and Sweden.
[PRO] Tourist spending as bellwetherIn February, while luxury brand Moncler was still basking in the glow of a stellar 20% share price surge from January, fund manager Giles Parkinson made a contrarian move: He sold out. Parkinson's caution wasn't borne out of analyst reports or traditional financial modeling, but from what he called a "good short-term guide to luxury industry writ large": the spending patterns of international tourists.
In China, 'The Great American' burger is now made with Australian beef
American agricultural products have been vanishing from Chinese stores and restaurants and losing ground to other imports.
At his restaurant in Beijing, Geng Xiaoyun used to offer a special dish of salt-baked chicken feet — or "phoenix talons" as they are called in China — imported from America.
"American chicken feet are so beautiful," Geng said. "They're spongy so they taste great. Chinese [chicken] feet just aren't as good."
With prices climbing 30% from March due to tariffs, the owner of Kunyuan restaurant had to pull the Chinese delicacy from the menu.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao
SHANGHAI, June 4, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that its new drugapplication (NDA) for the CAR-T cell immunotherapy product Carteyva® (relma-cel, targeting CD19) was approved by the Macao Special Administrative Region Government's Drug Regulatory Authority. This marks the first overseas market access for the product after its approval in mainland China, as well as a significant breakthrough in JW Therapeutics' global strategy. The approval covers three major indications, including: Adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy; Adult patients with refractory or relapsed within 24 months follicular lymphoma after two or more lines of systemic therapy; Adult patients with relapsed or refractory mantle cell lymphoma after second line or above systemic treatment, including treatment with Bruton tyrosine kinase JW Therapeutics' first commercial product, the marketing approval of Carteyva® in Macao will further expand its accessibility in hematological oncology. Mr. Min LiuChairman and CEO of JW Therapeutics"The approval of Carteyva® in Macao marks the official launch of JW Therapeutics' internationalization journey, demonstrating our technical strength and regulatory recognition in the field of cell therapy. As our first overseas market, Macao lays a solid foundation for our expansion into Asia-Pacific and global markets. In the future, we'll speed up regional commercialization and strengthen global R&D and manufacturing collaboration to offer hope to more patients." View original content: SOURCE JW Therapeutics Sign in to access your portfolio
Yahoo
17 minutes ago
- Yahoo
Jabil (JBL) Stock Declines While Market Improves: Some Information for Investors
Jabil (JBL) ended the recent trading session at $171.97, demonstrating a -0.59% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.01%. Meanwhile, the Dow experienced a drop of 0.22%, and the technology-dominated Nasdaq saw an increase of 0.32%. Heading into today, shares of the electronics manufacturer had gained 15.1% over the past month, outpacing the Computer and Technology sector's gain of 7.95% and the S&P 500's gain of 5.2% in that time. The upcoming earnings release of Jabil will be of great interest to investors. The company's earnings report is expected on June 17, 2025. The company's upcoming EPS is projected at $2.28, signifying a 20.63% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $6.98 billion, reflecting a 3.18% rise from the equivalent quarter last year. For the full year, the Zacks Consensus Estimates project earnings of $8.93 per share and a revenue of $27.82 billion, demonstrating changes of +5.18% and -3.68%, respectively, from the preceding year. Investors should also note any recent changes to analyst estimates for Jabil. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Jabil currently has a Zacks Rank of #4 (Sell). With respect to valuation, Jabil is currently being traded at a Forward P/E ratio of 19.37. This signifies a premium in comparison to the average Forward P/E of 19.3 for its industry. One should further note that JBL currently holds a PEG ratio of 1.55. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Electronics - Manufacturing Services industry had an average PEG ratio of 1.35 as trading concluded yesterday. The Electronics - Manufacturing Services industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 204, which puts it in the bottom 18% of all 250+ industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize to follow all of these stock-moving metrics, and more, in the coming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Jabil, Inc. (JBL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
General Dynamics (GD) Stock Sinks As Market Gains: Here's Why
General Dynamics (GD) closed at $275.03 in the latest trading session, marking a -0.37% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.01%. Elsewhere, the Dow saw a downswing of 0.22%, while the tech-heavy Nasdaq appreciated by 0.32%. Coming into today, shares of the defense contractor had gained 2.01% in the past month. In that same time, the Aerospace sector gained 9.52%, while the S&P 500 gained 5.2%. Investors will be eagerly watching for the performance of General Dynamics in its upcoming earnings disclosure. On that day, General Dynamics is projected to report earnings of $3.47 per share, which would represent year-over-year growth of 6.44%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $12.05 billion, up 0.59% from the year-ago period. For the full year, the Zacks Consensus Estimates are projecting earnings of $14.92 per share and revenue of $50.47 billion, which would represent changes of +9.46% and +5.76%, respectively, from the prior year. It is also important to note the recent changes to analyst estimates for General Dynamics. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.04% lower. At present, General Dynamics boasts a Zacks Rank of #3 (Hold). In terms of valuation, General Dynamics is currently trading at a Forward P/E ratio of 18.51. This expresses a discount compared to the average Forward P/E of 23.06 of its industry. It is also worth noting that GD currently has a PEG ratio of 1.86. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As of the close of trade yesterday, the Aerospace - Defense industry held an average PEG ratio of 1.94. The Aerospace - Defense industry is part of the Aerospace sector. At present, this industry carries a Zacks Industry Rank of 50, placing it within the top 21% of over 250 industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report General Dynamics Corporation (GD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data